2013 Apr 15 Annual Report 2012 - Phosphagenics

Consolidated statement of comprehensive income
FOR THE YEAR ENDED
31 DECEMBER 2012 Note
Revenue
2012
$’000
2011
$’000
Sale of goods 1,284 2,516
Licences 3a 246 228
Finance revenue 1,133 427
Total revenue 2,663 3,171
Cost of sales (733) (1,040)
Gross profit 1,930 2,131
64
Income from government grants 3b 3,355 1,236
Other income 157 143
Employee and Directors benefi ts expenses (4,602) (4,003)
Occupancy and communications expenses (686) (511)
Consulting and professional expenses (1,026) (933)
Administration expenses (1,846) (1,997)
Research expenses (3,151) (4,924)
Amortisation of acquired intangible assets (4,687) (2,389)
Impairment of available-for-sale investment - (706)
Other expenses 3c (499) (771)
Loss before income tax (11,055) (12,724)
Income tax benefi t 4 - 13,830
Profi t / (loss) after income tax (11,055) 1,106
Other Comprehensive Income
Foreign currency translation 14 11 (2)
Income tax/(expense) on items of other
- -
comprehensive income
Other comprehensive income for the period,
14 11 (2)
net of tax
Total comprehensive income for the period (11,044) 1,104
Profit / (loss) per share from continuing
operations attributable to the ordinary equity
holders of the parent:
Basic profi t / (loss) per share 15 (1.08) cents 0.13 cents
Diluted profi t / (loss) per share 15 (1.08) cents 0.13 cents
The above Statement of comprehensive income should be read in conjunction with the accompanying notes.
PHOSPHAGENICS ANNUAL REPORT 2012